These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


426 related items for PubMed ID: 15604289

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
    Gitelson E, Hammond C, Mena J, Lorenzo M, Buckstein R, Berinstein NL, Imrie K, Spaner DE.
    Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
    [Abstract] [Full Text] [Related]

  • 3. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
    de Totero D, Tazzari PL, Capaia M, Montera MP, Clavio M, Balleari E, Foa R, Gobbi M.
    Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
    [Abstract] [Full Text] [Related]

  • 4. Four novel ULBP splice variants are ligands for human NKG2D.
    Cao W, Xi X, Wang Z, Dong L, Hao Z, Cui L, Ma C, He W.
    Int Immunol; 2008 Aug; 20(8):981-91. PubMed ID: 18544572
    [Abstract] [Full Text] [Related]

  • 5. Evidence for B cell-mediated activation of V delta 1+ T lymphocytes during progression of HIV infection.
    Hyjek EM, Bartkowiak J, Drozdz R, Wasik TJ, Jasinski M, Kaneko Y, Lischner HW, Kozbor D.
    J Immunol; 1997 Jan 01; 158(1):464-74. PubMed ID: 8977224
    [Abstract] [Full Text] [Related]

  • 6. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.
    Eisele G, Wischhusen J, Mittelbronn M, Meyermann R, Waldhauer I, Steinle A, Weller M, Friese MA.
    Brain; 2006 Sep 01; 129(Pt 9):2416-25. PubMed ID: 16891318
    [Abstract] [Full Text] [Related]

  • 7. Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.
    Schrama D, Terheyden P, Otto K, Kämmerer U, Bröcker EB, Lühder F, Cosman D, Andersen MH, Becker JC.
    Eur J Immunol; 2006 Jan 01; 36(1):65-72. PubMed ID: 16342232
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative effects of interferon-gamma and all- trans retinoic acid on secreted and surface-associated matrix metalloproteinase-9 expression of human monocytes.
    Nguyen J, Dumont J, Bauvois B.
    Cell Mol Biol (Noisy-le-grand); 2006 May 15; 52(1):51-8. PubMed ID: 16914095
    [Abstract] [Full Text] [Related]

  • 11. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
    Trentin L, Zambello R, Sancetta R, Facco M, Cerutti A, Perin A, Siviero M, Basso U, Bortolin M, Adami F, Agostini C, Semenzato G.
    Cancer Res; 1997 Nov 01; 57(21):4940-7. PubMed ID: 9354461
    [Abstract] [Full Text] [Related]

  • 12. Molecular diversity of gammadelta T cells in peripheral blood from patients with B-cell chronic lymphocytic leukaemia.
    Bartkowiak J, Kulczyck-Wojdala D, Blonski JZ, Robak T.
    Neoplasma; 2002 Nov 01; 49(2):86-90. PubMed ID: 12088111
    [Abstract] [Full Text] [Related]

  • 13. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A, Rolinski J, Wasik-Szczepaneko E, Kaluzny Z, Dmoszynska A.
    Haematologica; 2002 May 01; 87(5):490-9. PubMed ID: 12010662
    [Abstract] [Full Text] [Related]

  • 14. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
    Schilbach K, Frommer K, Meier S, Handgretinger R, Eyrich M.
    J Immunother; 2008 May 01; 31(9):896-905. PubMed ID: 18832998
    [Abstract] [Full Text] [Related]

  • 15. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2005 Feb 01; 159(1-2):155-64. PubMed ID: 15652415
    [Abstract] [Full Text] [Related]

  • 16. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.
    Eleme K, Taner SB, Onfelt B, Collinson LM, McCann FE, Chalupny NJ, Cosman D, Hopkins C, Magee AI, Davis DM.
    J Exp Med; 2004 Apr 05; 199(7):1005-10. PubMed ID: 15051759
    [Abstract] [Full Text] [Related]

  • 17. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
    Djurdjevic P, Zelen I, Ristic P, Baskic D, Popovic S, Arsenijevic N.
    Arch Med Res; 2009 Jul 05; 40(5):357-63. PubMed ID: 19766898
    [Abstract] [Full Text] [Related]

  • 18. Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells.
    Kokhaei P, Palma M, Hansson L, Osterborg A, Mellstedt H, Choudhury A.
    Exp Hematol; 2007 Feb 05; 35(2):297-304. PubMed ID: 17258078
    [Abstract] [Full Text] [Related]

  • 19. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera.
    Shimoni A, Marcus H, Dekel B, Shkarchi R, Arditti F, Shvidel L, Shtalrid M, Bucher W, Canaan A, Ergas D, Berrebi A, Reisner Y.
    Cancer Res; 1999 Dec 01; 59(23):5968-74. PubMed ID: 10606243
    [Abstract] [Full Text] [Related]

  • 20. Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients.
    Giacomelli R, Matucci-Cerinic M, Cipriani P, Ghersetich I, Lattanzio R, Pavan A, Pignone A, Cagnoni ML, Lotti T, Tonietti G.
    Arthritis Rheum; 1998 Feb 01; 41(2):327-34. PubMed ID: 9485091
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.